Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2004-04-29
2009-12-01
Chong, Yong S (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S717000, C514S730000
Reexamination Certificate
active
07625950
ABSTRACT:
Compounds of formula (I)wherein R1, R2, R3, R4, R5, R6, R7, X, Y and n are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
REFERENCES:
patent: 0 778 263 (1997-06-01), None
patent: 1 002 792 (2000-05-01), None
patent: 98/45259 (1998-10-01), None
patent: 02/076995 (2002-10-01), None
patent: 2004/024673 (2004-03-01), None
Vessby et al., Cavedilol treatment of kidney graft recipients with chronic rejection. Clin. Transplantatiion 1999 13 484-490.
Chemical Abstract 129:95608 and Japanese Patent No. 10147587, date Jun. 2, 1998.
Hinterding Klaus
Spanka Carsten
Zecri Frederic
Chong Yong S
Hoxie & Associates LLC
Novartis AG
LandOfFree
Amino-propanol derivatives as sphingosine-1-phosphate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-propanol derivatives as sphingosine-1-phosphate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-propanol derivatives as sphingosine-1-phosphate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4142042